36C10G24Q0039.docx

Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice

GENERAL INFORMATION

SET-ASIDE

OPAL | Strategic Acquisition Center

10300 Spotsylvania Ave | STE 400 Fredericksburg VA 22408-2697

POINT OF CONTACT*

Contract Specialist Jalima Jones Jalima.Jones@va.gov 202-570-8856

PLACE OF PERFORMANCE

ADDRESS

Nationwide

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

DESCRIPTION

Solicitation Number:

36C10G24Q0039

Notice Type:

Combined Synopsis/Solicitation

Synopsis:

COMBINED SYNOPSIS/SOLICITATION

This is a combined synopsis/solicitation for brand name or equal commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, “Streamlined Procedures for Evaluation and Solicitation for Commercial Items,” as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested and a written solicitation will not be issued.

Solicitation number 36C10G24Q0039 is issued for this combined synopsis/solicitation; this solicitation is being issued as a Request for Quote (RFQ). This combined synopsis/solicitation incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2024-03, dated 23 February 2024.

Requirement Description:

VA has a requirement to purchase Detectors: Blood Flow: Ultrasonic to deliver patient care at its VA Medical Centers around the country. Detectors: Blood Flow: Ultrasonic: use ultrasonic techniques (e.g., Doppler effect) to determine the extent of peripheral vascular blood flow restrictions (e.g., clots, stenosis). These devices typically consist of a radio-frequency unit with and ultrasonic transducer probe, and an audio or visual indicator. Ultrasonic blood flow detectors can sense transcutaneously blood flow in all vessels outside the skull and thorax (i.e., vessels not blocked by bone or air); they are used in the assessment of atherosclerosis, varicose veins, and venous thrombosis; and also, in the diagnosis of the vascular state of the extremities.

A single award Requirements contract will be awarded IAW FAR 52.211-6 Brand Name or Equal in accordance with all terms, conditions, provisions, specifications, and schedule of this solicitation herein. Quotes shall contain the terms for cost/price and technical capabilities of the brand name or equal equipment. The Government reserves the right to award without discussions.

The associated North American Industrial Classification System (NAICS) code for this procurement is 339112 – Surgical and Medical Instrument Manufacturing: 6515 – Medical and Surgical Instruments, Equipment, and Supplies and the associated size standard is 850 employees. This procurement action is issued as full and open competition on an unrestricted basis.

This acquisition is for a single award Requirements contract in accordance with FAR Part 16.5 for Arjo HuntLeigh® brand name or equal Detectors: Blood Flow: Ultrasonic as identified in ATTACHMENT A – PRICE COST SCHEDULE - NX EQ DETECTORS: BLOOD FLOW: ULTRASONIC. All interested companies shall provide a quote for all Contract Line- Item Numbers (CLINs) listed in ATTACHMENT A – PRICE COST SCHEDULE - NX EQ DETECTORS: BLOOD FLOW: ULTRASONIC.

The ordering period is for one 12-month base year with four 12-month option years. Delivery is FOB destination. Firm-Fixed Price Orders will be placed against this contract in writing and will provide the delivery locations, delivery dates and exact quantities.

The FAR provision at 52.212-1, Instructions to Offerors – Commercial, applies to this acquisition including attached addenda to the provision.

The FAR provision at 52.212-2, Evaluation -- Commercial Items, and the specific evaluation criteria as attached addenda also applies to this acquisition.

The Offeror is to include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Items, with its offer.

Clause at 52.212-4, Contract Terms and Conditions -- Commercial Items, applies to this acquisition and a statement regarding any addenda to the clause. Addendum is attached.

Clause at 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders -- Commercial Items, applies to this acquisition and a statement regarding which, if any, of the additional FAR clauses cited in the clause are applicable to the acquisition. Addendum is attached.

All interested quoters must be registered in the System for Award Management (SAM) prior to submitting a quote. You may access SAM at https://sam.gov/SAM/.

Questions regarding this combined synopsis/solicitation are due via email by 4:30PM EST on March 13, 2024, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, William Milline at William.Milline@va.gov No calls will be accepted.

Quotes are due via email by 4:30PM EST on March 22, 2024, to Contract Specialist, Jalima Jones at Jalima.Jones@va.gov and Contracting Officer, William Milline at William.Milline@va.gov

1. SCOPE OF WORK

The Veterans Health Administration (VHA) Non-Expendable Equipment National Program has identified the Detectors: Blood Flow: Ultrasonic product line as a candidate for a VA-wide (otherwise referred to as “national”) single Requirements contract award.

Detectors: Blood Flow: Ultrasonic use ultrasonic techniques (e.g., Doppler effect) to determine the extent of peripheral vascular blood flow restrictions (e.g., clots, stenosis). These devices typically consist of a radio-frequency unit with and ultrasonic transducer probe, and an audio or visual indicator. Ultrasonic blood flow detectors can sense transcutaneously blood flow in all vessels outside the skull and thorax (i.e., vessels not blocked by bone or air); they are used in the assessment of atherosclerosis, varicose veins, and venous thrombosis; and also, in the diagnosis of the vascular state of the extremities.

The Contractor must demonstrate the ability to meet all requirements for the solicitation. The objective is to provide Detectors: Blood Flow: Ultrasonic to be used by clinicians throughout the VA medical centers and facilities. The period of performance is for one 12-month base period with four 12-month option years.

2. REQUIREMENT

This requirement will be IAW FAR clause 52.211-6, “Brand Name or Equal” which requires the offeror indicate that each product being offered as an “equal” product to the Arjo HuntLeigh® or equal, Detectors: Blood Flow: Ultrasonic. For each equal product, the offeror must include a description reflecting the salient characteristics (SC) and level of quality that will satisfy the salient physical, functional, or performance characteristics of the equal product(s) specified in the solicitation. The offeror must also clearly identify the item by brand name (if any) and make/model number. Finally, the offeror must include descriptive literature, such as illustrations, drawings, or a clear reference to previously furnished descriptive data or information available to the Contracting Officer, and clearly describe any modifications it plans to make to a product to make it conform to the solicitation requirements.

The following line items comprise Detectors: Blood Flow: Ultrasonic product line:

Contract Line Item#

Brand

Part Number

Description

The Department of Veterans Affairs (VA) is seeking vendors who can provide Arjo HuntLeigh® Detectors: Blood Flow: Ultrasonic or equal as listed above which meet all the following salient characteristics.

The Government intends for offerors to include all ancillary items, to ensure the equipment can function as designed by the OEM and as clinically required. Products quoted in the technical volume must be captured on the Vendor’s pricing volume (Attachment A - Price Cost Schedule) of the solicitation.

Additionally, responses can include any additional product and other product-related services necessary to obtain the supplies as required that may be beneficial and essential to the functionality of the proposed solution. These items must be clearly identified by brand name and part number.

When offerors include their additional proposed product items/services, these items may be considered for evaluation, and must be captured in the vendor’s pricing volume with an estimated quantity of zero.

Vendors may quote any product solution or configuration so long as they meet the salient characteristics. Products quoted in the technical volume must be captured on the Vendor’s pricing volume (Attachment A, Price Cost Schedule) of the solicitation. Vendors may quote any additional ancillary products which they deem to be essential to the functionality of the proposed solution; these items must be captured in the Vendor’s pricing volume with a quantity of zero.

The following attachments are incorporated by reference. All criteria outlined in the attachments are applicable to this combined synopsis/solicitation.

See attached document: ATTACHMENT A - PRICE COST SCHEDULE - NX EQ DETECTORS - BLOOD FLOW - ULTRASONIC.

See attached document: ATTACHMENT B - CONTRACT ADMINISTRATION - NX EQ DETECTORS BLOOD FLOW ULTRASONIC -.

See attached document: ATTACHMENT C - CONTRACT CLAUSES - NX EQ DETECTORS BLOOD FLOW ULTRASONIC -.

See attached document: ATTACHMENT D - SOLICITATION PROVISIONS - NX EQ DETECTORS BLOOD FLOW ULTRASONIC -.

See attached document: ATTACHMENT E - REPORTING TOOL - NX EQ DETECTORS - BLOOD FLOW - ULTRASONIC.

Combined Synopsis/Solicitation Notice